Master Alliance Provisions Guide (MAPGuide)

Cellscript – BioNTech mRNA Technology Patent Sublicense

  • Liability | Insurance

<p><span style=”textdecoration: underline;”><b>14. Insuranceb>span>p>
<p><strong>14.1 Coveragesstrong><span style=”fontweight: 400;”><strong>.strong> Company will procure and maintain insurance or selfinsurance that covers the following minimum liability amounts with respect to personal injury, bodily injury and property damage arising out of Companys performance under this Agreement: (a) during the Term, comprehensive general liability, including broad form and contractual liability, in a minimum amount of span>[***] combined single limit per occurrence and in the aggregate; (b) prior to the commencement of clinical trials involving Licensed Products, clinical trials a minimum amount of [***] combined single limit per occurrence and in the aggregate; and (c) prior to the Sale of the first Licensed Product, product liability a minimum amount of [***] <span style=”fontweight: 400;”>combined single limit per occurrence and in the aggregate. Penn and Cellscript may review periodically the adequacy of the minimum amounts of insurance or selfinsurance for each liability coverage area required by this Section 14.1, and Penn and Cellscript reserve the right to request Company to adjust the limits accordingly to the extent existing limits are not commercially reasonable. The required minimum amounts of insurance or selfinsurance do not constitute a limitation on Companys liability or indemnification obligations to Penn or Cellscript under this Agreement.span>p>